Evaluation of Quality Indicators on Analgesia, Sedation and Delirium in Intensive Care Patients and Their Impact on Outcome Indicators and Economic Indicators
1 other identifier
observational
20,220
1 country
1
Brief Summary
Retrospective cohort study to investigate the adherence to the process indicators for pain management, sedation management and management of delirium on outcome indicators and cost/revenues in individual patients and subcohorts.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started May 2022
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 12, 2022
CompletedFirst Submitted
Initial submission to the registry
May 17, 2022
CompletedFirst Posted
Study publicly available on registry
May 20, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 16, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
August 1, 2024
CompletedFebruary 14, 2025
February 1, 2025
8 months
May 17, 2022
February 12, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Influence of compliance to a quality indicator (Monitoring sedation, analgesia, delirium)
Influence of compliance to a quality indicator (Quality Indicator II of the DIVI; Management of Analgesia, Sedation and Delirium) and the relationship to case specific revenues and case costs according to case-specific analysis based on hospital financial data
01.01.2012- 31.12.2021
Secondary Outcomes (2)
Comorbidity scores
01.01.2012- 31.12.2021
Outcome indicators
01.01.2012- 31.12.2021
Eligibility Criteria
Electronically documented anesthesiological or intensive care treatment in the HIS (Hospital Information System) and PDMS (Patient Data Management System) of the Charité (Dep. for Anesthesiology with focus on operative intensive care, CCM/CVK) from 01.01.2012- 31.12.2021
You may qualify if:
- Age ≥ 18 years
You may not qualify if:
- Incomplete electronic records
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Charité - University Medicine Berlin
Berlin, 13353, Germany
Related Publications (1)
Zuber A, Rubarth K, Forster F, Balzer F, Spies C, Furstenau D, Kumpf O. The impact of adhering to a quality indicator for sedation, analgesia, and delirium management on costs, revenues, and clinical outcomes in intensive care in Germany: A retrospective observational study. PLoS One. 2024 Aug 15;19(8):e0308948. doi: 10.1371/journal.pone.0308948. eCollection 2024.
PMID: 39146321RESULT
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Claudia Spies, MD, Prof.
Charite University, Berlin, Germany
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Head of the Department of Anesthesiology and Intensive Care Medicine CCM/CVK, Charité - Universitätsmedizin Berlin
Study Record Dates
First Submitted
May 17, 2022
First Posted
May 20, 2022
Study Start
May 12, 2022
Primary Completion
January 16, 2023
Study Completion
August 1, 2024
Last Updated
February 14, 2025
Record last verified: 2025-02
Data Sharing
- IPD Sharing
- Will not share